While deletion of PKM2 accelerated breast cancer and medulloblastoma progression and promoted hepatocellular carcinoma [14, 15, 17], loss of PKM2 slowed leukemia progression [16] and had no effect on progression of colon cancer [12]. Here, PKM is linked to malignant colon neoplasm.